What are the differences in third-generation IVF technology?

What are the differences between third-generation IVF technology and traditional IVF?

Third-generation IVF, also known as preimplantation genetic diagnosis (PGD) or preimplantation genetic screening (PGS), is an advancement on traditional IVF. It primarily detects genetic diseases and chromosomal abnormalities in embryos to improve pregnancy rates and reduce the risk of genetic diseases.

**II. Technical Features**

Embryo Screening: Third-generation IVF allows for genetic and chromosomal screening of embryos before implantation, ensuring that only healthy embryos are selected for implantation.

**Reduced Risk of Genetic Diseases:** Suitable for couples with a family history of genetic diseases or chromosomal abnormalities, effectively reducing the chances of their offspring inheriting these conditions.

**Multiple Techniques:** Utilizes techniques including, but not limited to, single-cell genome sequencing, FISH (fluorescence in situ hybridization), and NGS (next-generation sequencing) for more precise analysis of embryonic genetic information.

**III. Advantages**

**Increased Pregnancy Rate:** By screening for healthy embryos, the probability of successful pregnancy is increased, especially for women with a history of multiple miscarriages.

** Reduced Birth Rate: Avoiding the implantation of embryos with serious genetic diseases reduces the incidence of birth defects and congenital diseases.

Sex Selection: In some countries and regions, PGD can be used for sex selection to help avoid sex-related genetic diseases.

Fertility Options: Providing more fertility options helps families plan for a healthier future.

IV. Timeline

The entire third-generation IVF process typically takes several months and includes the following stages:

Preliminary Consultation and Examination: Physical examinations and genetic counseling are conducted to assess suitability, usually taking 1 to 2 weeks.

Ovulation Induction Stage: Ovulation induction is performed using medication, generally taking 10 to 14 days. Regular checkups at the hospital are necessary to monitor follicle development during this period.

Egg Retrieval and Fertilization: Egg retrieval is usually performed within 14 days after ovulation induction, followed immediately by in-vitro fertilization.

Embryo Culture: Fertilized embryos are cultured in a laboratory for 3 to 5 days for genetic screening.

Embryo Transfer: Healthy embryos are selected for implantation after screening, usually on day 5 of embryo culture. Waiting for a pregnancy test: A pregnancy test is performed approximately 10 to 14 days after implantation to confirm pregnancy.

V. Suitable Patients

Advanced Age Women: Women over 35 years of age may have declining egg quality and are suitable candidates for third-generation IVF technology.

Families with a Family History of Genetic Diseases: Couples with a family history of genetic diseases can screen embryos using PGD technology to prevent the transmission of genetic diseases.

Patients with Multiple Miscarriages: Women who have experienced multiple miscarriages may have embryonic chromosomal abnormalities and are suitable candidates for screening.

Patients with Unexplained Infertility: For patients who have tried to conceive multiple times without success, genetic testing may reveal underlying problems.